Electrocrystallization of calcium oxalate on electrospun PCL fibers loaded with phytic acid as a template
Author
dc.contributor.author
Zegers Arce, Tatiana
Author
dc.contributor.author
Yazdani-Pedram Zobeiri, Mehrdad
Author
dc.contributor.author
Neira Carrillo, Andrónico David
Admission date
dc.date.accessioned
2023-03-08T14:48:16Z
Available date
dc.date.available
2023-03-08T14:48:16Z
Publication date
dc.date.issued
2022
Cita de ítem
dc.identifier.citation
Polymers 2022, 14, 3190
es_ES
Identifier
dc.identifier.other
10.3390/ polym14153190
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/191966
Abstract
dc.description.abstract
Crystallization occurs widely in living organisms where different organs could associate
with the calcification process, such as the formation of calcium oxalate (CaOx) calculi in the urinary
tract. However, the pathogenesis and the role of an inhibitor in the pathological processes involved in
urolithiasis is poorly understood. Therefore, the use of phytic acid (PA) as an inhibitor for the organic
fibrillar matrix is a novel approach to inhibit the formation of pathological CaOx crystals. Herein,
electrospun polymer fiber meshes of polycaprolactone (PCL) with random (R) and aligned (A) fiber
orientations containing PA were prepared by electrospinning, and their role as a 3D organic template
in in vitro CaOx crystallization was investigated. CaOx crystals were generated on conductive tin
indium oxide (ITO)-modified glass with R-PCL and A-PCL fibers in the presence of PA through
an electrocrystallization (EC) procedure. This study provides a simple electrochemical approach to
evaluate the role of PA as an inhibitor in the nucleation of pathological CaOx crystals. The resulting
CaOx crystals were analyzed by chrono-potentiometry, optical microscopy (OM), scanning electron
microscopy (SEM), and X-ray diffraction (XRD). We found that PA and the fiber orientations are key
factors in the nucleation and crystal growth of CaOx, achieving the stabilization of healthy CaOx
crystal and the inhibition of the pathological crystal form.
es_ES
Patrocinador
dc.description.sponsorship
ANID/FONDECYT/1211345
es_ES
Lenguage
dc.language.iso
en
es_ES
Publisher
dc.publisher
MDPI
es_ES
Type of license
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 United States